Elisa Tests Market, by Type (Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, Competitive ELISA), by Application (Immunology, Pharmaceutical and Vaccine Development, Allergy and Infectious diseases, Cancer, Protein quantitation, Animal and Food, Other), by Product Type (Consumables, Instruments) and, by End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

ELISA (which stands for enzyme-linked immunosorbent assay) is the basic assay technique that is carried out to detect and measure antibodies, hormones, peptides and proteins in the blood. Antibodies are blood proteins produced in response to a specific antigen in case of certain infectious diseases. ELISA is a biochemical reaction in which antigen is adsorbed on a solid surface. An antibody linked to an enzyme is allowed with the antigen and is detected by adding a substrate specific to the linked enzyme. ELISA test plays very important role in the diagnosis of several viral infections and is also used in pharmaceutical quality control tests such as endotoxin tests, protein quantification.

COVID-19 scenario analysis

At the early phase of COVID-19 pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global market. According to Department of Science and Technology, ELISA test is not only useful as a routine sero-survey tool to establish a previous infection, but even more importantly, as a quantifier of antibodies to address such critical questions as the rate of fading of antibodies, and in general, understanding of biological responses that depend on the quantity of antibodies, such as the efficacy of vaccines in generating antibodies and vaccine breakthroughs. On a related note, this technique will also play a very big role in elucidating seroconversion response to COVID-19 vaccines, and thereby play a supporting role in vaccination programs in future.

Therefore COVID 19 is going to propel the growth of the market.

Top impacting factors: market scenario analysis, trends, drivers and impact analysis

The factors such as the increasing of the prevalence of the chronic and infectious diseases including including the outbreak of COVID-19, the rise in the geriatric population, increasing R&D investment in ELISA development kits, improvement in the healthcare infrastructure, and growth in the biotechnology and biopharmaceutical industries will propel the growth of market in the forecast period. An antibody test can identify whether or not a person has been exposed to SARS-CoV-2 and whether or not they have developed immunity against SARS-CoV-2 infection. This test is generally is better suited for vaccine development and public health surveillance. The FDA has, so far, issued Emergency Authorization Use to twelve antibody tests, including four chemiluminescent assays, three colloidal gold assays, and five ELISA assays. 

New product launches to flourish the market

The launch of new products that contain improved capabilities have been launched by leading market players.Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. has created three enzyme-linked immunosorbent assay (ELISA) kits, designed to work with the total antibodies (Ab), IgM, and IgG of SARS-CoV-2 respectively.

Key benefits of the report

• This study presents the analytical depiction of the global ELISA tests market along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the ELISA Tests Market share.
• The current market is quantitatively analyzed to highlight the ELISA Tests Market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
• The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions answered in the ELISA tests market report

• Which are the leading players active in the ELISA tests market?
• What are the current trends that will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities of the ELISA tests market?
• What are the projections for the future that would help in taking further strategic steps?

  Elisa Tests Market, by Type Report Highlights

Aspects	Details
By Type	Sandwich ELISA Indirect ELISA Multiple and portable ELISA Competitive ELISA
By Application	Immunology Large Molecules Small Molecules Pharmaceutical and Vaccine Development Large Molecules Small Molecules Allergy and Infectious diseases Large Molecules Small Molecules Cancer Large Molecules Small Molecules Protein quantitation Large Molecules Small Molecules Animal and Food Large Molecules Small Molecules Other
By Product Type	Consumables Instruments
By End User	Hospitals and Diagnostic Centers Pharmaceutical and Biotech Companies Academic Research Centers Clinical Laboratories Others
By Region	North America  (U.S., Canada, Mexico) Europe  (UK, Germany, France, Spain, Italy, Rest of Europe) Asia-Pacific  (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific) LAMEA  (Latin America, Middle East, Africa)
Key Market Players	Bio-Rad Laboratories, ZEUS Scientific, Agilent Technologies, Abcam Plc, Thermofisher, ARBOR, Promega Corporation, Enzo Life Sciences, Merck & Co, Cell Biolabs (US)

^*Terms and Conditions Apply